These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 25028262

  • 1. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
    Onen HI, Yilmaz A, Alp E, Celik A, Demiroz SM, Konac E, Kurul IC, Menevse ES.
    Hum Exp Toxicol; 2015 Feb; 34(2):117-26. PubMed ID: 25028262
    [Abstract] [Full Text] [Related]

  • 2. Effects of cisplatin and panobinostat on human mesothelial (Met-5A) and malignant pleural mesothelioma (MSTO-211H) cells.
    Gultekin KE, Yurdakonar MK, Yaman E, Yuce US, Yilmaz A, Alp E, Celik A, Demiroz SM, Onen HI.
    Genet Mol Res; 2013 Nov 11; 12(4):5405-13. PubMed ID: 24301913
    [Abstract] [Full Text] [Related]

  • 3. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
    Hartman ML, Esposito JM, Yeap BY, Sugarbaker DJ.
    J Thorac Cardiovasc Surg; 2010 May 11; 139(5):1233-40. PubMed ID: 19853261
    [Abstract] [Full Text] [Related]

  • 4. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.
    Yamaji M, Ota A, Wahiduzzaman M, Karnan S, Hyodo T, Konishi H, Tsuzuki S, Hosokawa Y, Haniuda M.
    Cancer Med; 2017 Nov 11; 6(11):2646-2659. PubMed ID: 28960945
    [Abstract] [Full Text] [Related]

  • 5. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
    Borchert S, Suckrau PM, Walter RFH, Wessolly M, Mairinger E, Steinborn J, Hegedus B, Hager T, Herold T, Eberhardt WEE, Wohlschlaeger J, Aigner C, Bankfalvi A, Schmid KW, Mairinger FD.
    Sci Rep; 2020 Oct 29; 10(1):18677. PubMed ID: 33122816
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.
    Varin E, Denoyelle C, Brotin E, Meryet-Figuière M, Giffard F, Abeilard E, Goux D, Gauduchon P, Icard P, Poulain L.
    Carcinogenesis; 2010 Jun 29; 31(6):984-93. PubMed ID: 20142415
    [Abstract] [Full Text] [Related]

  • 7. Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma.
    Moriya M, Yamada T, Tamura M, Ishikawa D, Hoda MA, Matsumoto I, Klepetko W, Oda M, Yano S, Watanabe G.
    Oncol Rep; 2014 Mar 29; 31(3):1109-15. PubMed ID: 24378576
    [Abstract] [Full Text] [Related]

  • 8. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
    Stewart JH, Tran TL, Levi N, Tsai WS, Schrump DS, Nguyen DM.
    J Surg Res; 2007 Jul 29; 141(1):120-31. PubMed ID: 17574045
    [Abstract] [Full Text] [Related]

  • 9. Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous cell carcinoma.
    Lin C, Tu C, Ma Y, Ye P, Shao X, Yang Z, Fang Y.
    Mol Med Rep; 2017 Oct 29; 16(4):4927-4933. PubMed ID: 28791378
    [Abstract] [Full Text] [Related]

  • 10. Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.
    Riquelme E, Suraokar MB, Rodriguez J, Mino B, Lin HY, Rice DC, Tsao A, Wistuba II.
    J Thorac Oncol; 2014 Jul 29; 9(7):998-1007. PubMed ID: 24926545
    [Abstract] [Full Text] [Related]

  • 11. 2-Deoxy-glucose Enhances the Effect of Cisplatin and Pemetrexed in Reducing Malignant Pleural Mesothelioma Cell Proliferation But Not Spheroid Growth.
    Gerogianni I, Pitaraki E, Jagirdar RM, Kouliou O, Giannakou L, Giannopoulos S, Papazoglou E, Hatzoglou C, Gourgoulianis KI, Zarogiannis SG.
    Anticancer Res; 2019 Jul 29; 39(7):3809-3814. PubMed ID: 31262908
    [Abstract] [Full Text] [Related]

  • 12. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
    Spugnini EP, Cardillo I, Verdina A, Crispi S, Saviozzi S, Calogero R, Nebbioso A, Altucci L, Cortese G, Galati R, Chien J, Shridhar V, Vincenzi B, Citro G, Cognetti F, Sacchi A, Baldi A.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6133-43. PubMed ID: 17062690
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells.
    Chae JI, Jeon YJ, Shim JH.
    Oncol Rep; 2013 Jun 15; 29(6):2318-24. PubMed ID: 23525508
    [Abstract] [Full Text] [Related]

  • 14. Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma.
    Katz SI, Zhou L, Chao G, Smith CD, Ferrara T, Wang W, Dicker DT, El-Deiry WS.
    Cancer Biol Ther; 2009 Dec 15; 8(24):2406-16. PubMed ID: 20038816
    [Abstract] [Full Text] [Related]

  • 15. Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells.
    Lee YJ, Lee YJ, Im JH, Won SY, Kim YB, Cho MK, Nam HS, Choi YJ, Lee SH.
    Food Chem Toxicol; 2013 Feb 15; 52():61-8. PubMed ID: 23146690
    [Abstract] [Full Text] [Related]

  • 16. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
    Opitz I, Sigrist B, Hillinger S, Lardinois D, Stahel R, Weder W, Hopkins-Donaldson S.
    Lung Cancer; 2007 Jun 15; 56(3):327-36. PubMed ID: 17383050
    [Abstract] [Full Text] [Related]

  • 17. Role of transcription factor Sp1 in the quercetin-mediated inhibitory effect on human malignant pleural mesothelioma.
    Chae JI, Cho JH, Lee KA, Choi NJ, Seo KS, Kim SB, Lee SH, Shim JH.
    Int J Mol Med; 2012 Oct 15; 30(4):835-41. PubMed ID: 22842769
    [Abstract] [Full Text] [Related]

  • 18. Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts.
    Littlejohn JE, Cao X, Miller SD, Ozvaran MK, Jupiter D, Zhang L, Rodarte C, Smythe WR.
    Int J Cancer; 2008 Jul 01; 123(1):202-8. PubMed ID: 18360826
    [Abstract] [Full Text] [Related]

  • 19. The flavonoid resveratrol suppresses growth of human malignant pleural mesothelioma cells through direct inhibition of specificity protein 1.
    Lee KA, Lee YJ, Ban JO, Lee YJ, Lee SH, Cho MK, Nam HS, Hong JT, Shim JH.
    Int J Mol Med; 2012 Jul 01; 30(1):21-7. PubMed ID: 22552784
    [Abstract] [Full Text] [Related]

  • 20. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.
    Hoda MA, Pirker C, Dong Y, Schelch K, Heffeter P, Kryeziu K, van Schoonhoven S, Klikovits T, Laszlo V, Rozsas A, Ozsvar J, Klepetko W, Döme B, Grusch M, Hegedüs B, Berger W.
    Mol Cancer Ther; 2016 Oct 01; 15(10):2357-2369. PubMed ID: 27512118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.